Victory Capital Management Inc. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 221,594 shares of the healthcare conglomerate’s stock after selling 1,288 shares during the quarter. Victory Capital Management Inc.’s holdings in UnitedHealth Group were worth $36,343,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in UNH. Capital Wealth Planning LLC acquired a new position in UnitedHealth Group in the first quarter worth $3,245,000. Cipher Capital LP boosted its holdings in UnitedHealth Group by 25.4% in the first quarter. Cipher Capital LP now owns 20,446 shares of the healthcare conglomerate’s stock worth $3,354,000 after purchasing an additional 4,145 shares during the period. Parkside Investments LLC acquired a new position in UnitedHealth Group in the first quarter worth $2,804,000. Clinton Group Inc. boosted its holdings in UnitedHealth Group by 89.4% in the first quarter. Clinton Group Inc. now owns 56,017 shares of the healthcare conglomerate’s stock worth $9,187,000 after purchasing an additional 26,440 shares during the period. Finally, Mckinley Capital Management LLC Delaware boosted its holdings in UnitedHealth Group by 5.0% in the first quarter. Mckinley Capital Management LLC Delaware now owns 171,940 shares of the healthcare conglomerate’s stock worth $28,200,000 after purchasing an additional 8,240 shares during the period. 86.21% of the stock is owned by institutional investors and hedge funds.
A number of equities analysts have commented on the stock. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Cantor Fitzgerald reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 29th. UBS AG reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a report on Friday, August 18th. Finally, Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. One analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $203.41.
Shares of UnitedHealth Group Incorporated (NYSE UNH) traded up 0.23% during midday trading on Friday, reaching $198.18. 4,198,691 shares of the company’s stock traded hands. The stock’s 50 day moving average price is $195.28 and its 200 day moving average price is $180.64. The firm has a market capitalization of $191.61 billion, a P/E ratio of 23.81 and a beta of 0.63. UnitedHealth Group Incorporated has a 52-week low of $133.03 and a 52-week high of $200.76.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same quarter in the prior year, the firm posted $1.96 earnings per share. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.51%. The ex-dividend date of this dividend is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the transaction, the director now owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the transaction, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders have sold 25,600 shares of company stock worth $4,962,694 in the last ninety days. 0.89% of the stock is currently owned by insiders.
TRADEMARK VIOLATION WARNING: This report was published by BBNS and is the property of of BBNS. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://baseballnewssource.com/markets/victory-capital-management-inc-lowers-stake-in-unitedhealth-group-incorporated-unh/1566125.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with our FREE daily email newsletter.